Clinical Trial Update: Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of panitumumab with cisplatin, fluorouracil, and docetaxel in locally advanced or metastatic gastric cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• Panitumumab (panitumumab)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: TERMINATED